Dr Ashita Waterston
- Honorary Clinical Senior Lecturer (School of Medicine, Dentistry & Nursing)
The University of Glasgow uses cookies for analytics. Find out more about our Privacy policy.
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and can only be disabled by changing your browser preferences.
Analytical cookies help us improve our website. We use Google Analytics. All data is anonymised.
Clarity helps us to understand our users’ behaviour by visually representing their clicks, taps and scrolling. All data is anonymised.
Zeidaabadi, Boroumand, Glen, Claire, Barker, Joseph, Peck, Oliver H., Tan, Yun Y., Waterston, Ashita, Squire, Iain, Sau, Arunashis, Lang, Ninian N. ORCID: https://orcid.org/0000-0001-8441-6887 and Ng, Fu Siong
(2026)
Artificial Intelligence-enhanced electrocardiography for prediction of cancer therapy-related cardiac dysfunction.
EP Europace,
(Accepted for Publication)
Iveson, T. et al. (2026) Three versus 6 months of adjuvant oxaliplatin-fluoropyrimidine chemotherapy for colorectal cancer: final results of SCOT—an international, randomized, phase III, noninferiority trial. Journal of Clinical Oncology, 44(7), pp. 534-539. (doi: 10.1200/jco-25-00621) (PMID:41512219) (PMCID:PMC12931879)
Zeidaabadi, Boroumand, Glen, Claire, Barker, Joseph, Peck, Oliver H., Tan, Yun Y., Waterston, Ashita, Squire, Iain, Sau, Arunashis, Lang, Ninian N. ORCID: https://orcid.org/0000-0001-8441-6887 and Ng, Fu Siong
(2026)
Artificial Intelligence-enhanced electrocardiography for prediction of cancer therapy-related cardiac dysfunction.
EP Europace,
(Accepted for Publication)
Iveson, T. et al. (2026) Three versus 6 months of adjuvant oxaliplatin-fluoropyrimidine chemotherapy for colorectal cancer: final results of SCOT—an international, randomized, phase III, noninferiority trial. Journal of Clinical Oncology, 44(7), pp. 534-539. (doi: 10.1200/jco-25-00621) (PMID:41512219) (PMCID:PMC12931879)